44.16
0.00 (0.00%)
0.00 (0.00%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd | BHVN | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 3.34 | 8.18% | 44.16 | 40.80 | 44.20 | 41.50 | 40.82 | 20:00:00 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 14,709 | 1,874,340 | $ 42.31 | $ 79,312,341 | 1,147,405 | 36.69 - 67.86 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:30:00 | 152,256 | $ 44.16 | USD |
Biohaven Pharmaceutical Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 2.52B | 57.07M | $ -240.92M | -6.19 | - | 51.26M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 7.97M | $ - | 0.00% | - | - |
Biohaven Pharmaceutical News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BHVN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 45.80 | 45.91 | 40.78 | 43.84 | 832,495 | -1.64 | -3.58% |
| 1 Month | 48.70 | 54.88 | 38.50 | 47.45 | 1,102,828 | -4.54 | -9.32% |
| 3 Months | 55.20 | 62.00 | 38.50 | 51.07 | 946,120 | -11.04 | -20.0% |
| 6 Months | 37.58 | 62.00 | 37.08 | 49.05 | 776,671 | 6.58 | 17.51% |
| 1 Year | 44.86 | 67.86 | 36.69 | 48.78 | 804,670 | -0.70 | -1.56% |
| 3 Years | 20.00 | 67.86 | 16.5001 | 40.81 | 516,839 | 24.16 | 120.8% |
| 5 Years | 20.00 | 67.86 | 16.5001 | 40.81 | 516,839 | 24.16 | 120.8% |
Biohaven Pharmaceutical Description
| Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. Its product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. The company's pipeline products include BHV3000-301, BHV3000-302, BHV3000-303 and others. |
